These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32031495)

  • 1. Vascular Disease Patient Information Page: Direct oral anticoagulants - 2020 update.
    Vazquez SR
    Vasc Med; 2020 Apr; 25(2):196-199. PubMed ID: 32031495
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH.
    Martin K; Beyer-Westendorf J; Davidson BL; Huisman MV; Sandset PM; Moll S
    J Thromb Haemost; 2016 Jun; 14(6):1308-13. PubMed ID: 27299806
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of well managed warfarin. A report from the Swedish quality register Auricula.
    Sjögren V; Grzymala-Lubanski B; Renlund H; Friberg L; Lip GY; Svensson PJ; Själander A
    Thromb Haemost; 2015 Jun; 113(6):1370-7. PubMed ID: 25716771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Edoxaban in venous thromboembolism and stroke prevention: an appraisal.
    Proietti M; Lip GY
    Vasc Health Risk Manag; 2016; 12():45-51. PubMed ID: 27013883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.
    Korenstra J; Wijtvliet EP; Veeger NJ; Geluk CA; Bartels GL; Posma JL; Piersma-Wichers M; Van Gelder IC; Rienstra M; Tieleman RG
    Europace; 2016 Sep; 18(9):1319-27. PubMed ID: 26843571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct Oral Anticoagulants in Octogenarians With Atrial Fibrillation: It Is Never Too Late.
    Russo V; Carbone A; Rago A; Golino P; Nigro G
    J Cardiovasc Pharmacol; 2019 Apr; 73(4):207-214. PubMed ID: 30855404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
    Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
    J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State of play and future direction with NOACs: An expert consensus.
    Cohen AT; Lip GY; De Caterina R; Heidbuchel H; Zamorano JL; Agnelli G; Verheugt F; Camm AJ
    Vascul Pharmacol; 2018 Jul; 106():9-21. PubMed ID: 29656119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.
    Stabile E; Izzo R; Rozza F; Losi MA; Coscioni E; Trimarco B
    High Blood Press Cardiovasc Prev; 2016 Jun; 23(2):115-22. PubMed ID: 27207360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's New in Anticoagulation.
    Razavi JE; Safavi-Naeini P; Razavi M
    Tex Heart Inst J; 2016 Oct; 43(5):419-421. PubMed ID: 27777526
    [No Abstract]   [Full Text] [Related]  

  • 12. The Comparison of Inappropriate-Low-Doses Use among 4 Direct Oral Anticoagulants in Patients with Atrial Fibrillation: From the Database of a Single-Center Registry.
    Sato T; Aizawa Y; Fuse K; Fujita S; Ikeda Y; Kitazawa H; Takahashi M; Okabe M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3280-3288. PubMed ID: 30121155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct oral anticoagulants: unique properties and practical approaches to management.
    Barnes GD; Kurtz B
    Heart; 2016 Oct; 102(20):1620-6. PubMed ID: 27402803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboembolic risk and effect of oral anticoagulation according to atrial fibrillation patterns: A systematic review and meta-analysis.
    Lilli A; Di Cori A; Zacà V
    Clin Cardiol; 2017 Sep; 40(9):641-647. PubMed ID: 28471498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation.
    Prídavková D; Samoš M; Bolek T; Škorňová I; Žolková J; Kubisz P; Staško J; Mokáň M
    J Diabetes Res; 2019; 2019():5158308. PubMed ID: 31886279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bridging conundrum: perioperative management of direct oral anticoagulants for venous thromboembolism.
    Berry J; Patell R; Zwicker JI
    J Thromb Haemost; 2023 Apr; 21(4):780-786. PubMed ID: 36709100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH.
    Carlin S; Cuker A; Gatt A; Gendron N; Hernández-Gea V; Meijer K; Siegal DM; Stanworth S; Lisman T; Roberts LN
    J Thromb Haemost; 2024 Sep; 22(9):2653-2669. PubMed ID: 38823454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quick reference guide to apixaban.
    Hurst KV; O'Callaghan JM; Handa A
    Vasc Health Risk Manag; 2017; 13():263-267. PubMed ID: 28744136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectively Initiating and Maintaining Anticoagulation in Patients With Atrial Fibrillation.
    Wang TY
    Circulation; 2019 Apr; 139(15):1763-1765. PubMed ID: 30958715
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.
    Park YK; Lee MJ; Kim JH; Lee JS; Park RW; Kim GM; Chung CS; Lee KH; Kim JS; Lee SY; Bang OY
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1383-1390. PubMed ID: 28412319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.